Standard BioTools Retained Earnings (Accumulated Deficit) 2010-2024 | LAB
Standard BioTools retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Standard BioTools Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-1,001 |
| 2022 | $-926 |
| 2021 | $-736 |
| 2020 | $-677 |
| 2019 | $-624 |
| 2018 | $-559 |
| 2017 | $-500 |
| 2016 | $-439 |
| 2015 | $-363 |
| 2014 | $-310 |
| 2013 | $-257 |
| 2012 | $-241 |
| 2011 | $-222 |
| 2010 | $-199 |
| 2009 | $-182 |
| Standard BioTools Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-1,152 |
| 2024-06-30 | $-1,125 |
| 2024-03-31 | $-1,079 |
| 2023-12-31 | $-1,001 |
| 2023-09-30 | $-981 |
| 2023-06-30 | $-960 |
| 2023-03-31 | $-943 |
| 2022-12-31 | $-926 |
| 2022-09-30 | $-905 |
| 2022-06-30 | $-876 |
| 2022-03-31 | $-812 |
| 2021-12-31 | $-736 |
| 2021-09-30 | $-727 |
| 2021-06-30 | $-713 |
| 2021-03-31 | $-696 |
| 2020-12-31 | $-677 |
| 2020-09-30 | $-659 |
| 2020-06-30 | $-653 |
| 2020-03-31 | $-640 |
| 2019-12-31 | $-624 |
| 2019-09-30 | $-611 |
| 2019-06-30 | $-598 |
| 2019-03-31 | $-584 |
| 2018-12-31 | $-559 |
| 2018-09-30 | $-544 |
| 2018-06-30 | $-529 |
| 2018-03-31 | $-513 |
| 2017-12-31 | $-500 |
| 2017-09-30 | $-490 |
| 2017-06-30 | $-474 |
| 2017-03-31 | $-457 |
| 2016-12-31 | $-439 |
| 2016-09-30 | $-422 |
| 2016-06-30 | $-402 |
| 2016-03-31 | $-383 |
| 2015-12-31 | $-363 |
| 2015-09-30 | $-351 |
| 2015-06-30 | $-341 |
| 2015-03-31 | $-326 |
| 2014-12-31 | $-310 |
| 2014-09-30 | $-299 |
| 2014-06-30 | $-285 |
| 2014-03-31 | $-273 |
| 2013-12-31 | $-257 |
| 2013-09-30 | $-253 |
| 2013-06-30 | $-248 |
| 2013-03-31 | $-244 |
| 2012-12-31 | $-241 |
| 2012-09-30 | $-237 |
| 2012-06-30 | $-233 |
| 2012-03-31 | $-228 |
| 2011-12-31 | $-222 |
| 2011-09-30 | $-218 |
| 2011-06-30 | $-214 |
| 2011-03-31 | $-207 |
| 2010-12-31 | $-199 |
| 2010-09-30 | $-196 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.651B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $5.669B | 176.81 |
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.799B | 0.00 |
| Enovis (ENOV) | United States | $2.475B | 16.78 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| 10x Genomics (TXG) | United States | $1.718B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |